Infectious diseases Point-of-Care (POC) Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Infectious Diseases Point-of-Care (POC) Diagnostic Market: By Component Type (Instruments, Reagents and Kits, Software and Services), By Technology (Lateral Flow Immunoassay, Agglutination Test, Molecular Diagnostics, others), By Disease (HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others) By End User (Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others) and Geograpy

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

Infectious Disease Point of Care Diagnostics Market size is valued at USD 2,547.8 million in 2021 and expected to grow at a significant CAGR of 7.2% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Global Infectious Disease Point of Care Diagnostics market and that can be segmented by components, by technique, by disease, and end-user. By components, The global infectious disease point of care diagnostics market has been segmented into Instruments, Reagents and Kits, Software and Services. The instruments segment is likely to be the largest and fastest-growing segment in terms of type. Based on technique, the global infectious disease point of care diagnostics market is segmented into Lateral flow immunoassay, Agglutination test, Molecular Diagnostics, and others. Among these, the lateral flow immunoassay segment is expected to have the fastest-growing market during the forecast period 2022-2028. By disease, the global infectious disease point of care diagnostics market is segmented into HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others. The respiratory tract infections segment accounts for the largest share in 2021. Hospital acquired infections is the second-largest share during the forecast period 2021-2028. Based on the end-user, the market has been segregated into Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others. The Hospitals and clinics segment is expected to dominate other segments in the global infectious disease point of care diagnostics market. The home care segment is expected to witness the highest CAGR during the forecast period according to precision business insights.

Key Development:

In April 2021 Chembio Diagnostics, Inc. launched the rapid point-of-care COVID-19/flu A&B test. The test provides results in 15 min.

Infectious Diseases Point-of-Care (POC) Diagnostic Market

MARKET SUMMARY

7.2% CAGR

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 7.2%
Largest Market– Asia-Pacific
Fastest Growing Market– North-America

Infectious Diseases Point-of-Care (POC) Diagnostic

The infectious diseases point-of-care (poc) diagnostic market report gives comprehensive outlook on semen analysis across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The infectious diseases point-of-care (poc) diagnostic market report gives historical, current, and future market sizes (US$ Mn) on by components, by technique, by disease, end-user and geography.

Key Players

Cepheid Inc.
Siemens AG
Beckman Coulter, Inc
Abbott Laboratories, Inc.
Hoffmann La Roche Limited

Infectious Diseases Point-of-Care (POC) Diagnostic Market

Drivers

The key driving forces for the point-of-care infectious disease diagnostics market is to increase in the prevalence of infectious diseases such as HBV, HCV, HAIs, RTI, and others coupled with launch of advanced diagnostic test kits by the market players across the globe. Moreover, outbreak of COVID-19 drastically increased the revenue in 2020 and 2021.

North-America Got Significant Share

Infectious diseases Point-of-Care (POC) Diagnostic Market

North America market is expected to witness highest market share during the forecast period.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Infectious Diseases Point-of-Care (POC) Diagnostic Market Segmentation

By Component Type

Instruments
Reagents and Kits
Software and Services

By Technology

Lateral Flow Immunoassay
Agglutination Test
Molecular Diagnostics
others

By Disease type

HIV
Hospital Acquired Infections
HBV
Respiratory Tract Infections
HPV
HCV
Tuberculosis
COVID-19
Others

By End User

Home Care
Hospitals and Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others

Location

GEOGRAPHY

Frequently Asked Questions

The Infectious Diseases Point-of-Care (POC) Diagnostic Market is projected to expand at a CAGR of 7.2% during the forecast period.

The major players in the global infectious disease point of care diagnostics market are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson, and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Quidel Corporation (U.S.)

North-America is the fastest-growing region for Infectious Diseases Point-of-Care (POC) Diagnostic Market

Report

Table Of Content

1. Executive Summary

2. Global Infectious Disease Point of Care Diagnostics Market Introduction

2.1. Global Infectious Disease Point of Care Diagnostics Market – Taxonomy

2.2. Global Infectious Disease Point of Care Diagnostics Market –Definitions

2.2.1. By Components

2.2.2. By Technology

2.2.3. By Disease Type

2.2.4. By End User

2.2.5. By Region

3. Global Infectious Disease Point of Care Diagnostics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Infectious Disease Point of Care Diagnostics Market Dynamic Factors – Impact Analysis

3.6. Global Infectious Disease Point of Care Diagnostics Market – Competition Landscape

3.7. Epidemiology

4. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028

4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Infectious Disease Point of Care Diagnostics Market, By Components, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1. Instruments

5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Reagents and Kits

5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Software and Services

5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6. Global Infectious Disease Point of Care Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1. Lateral Flow Immunoassay

6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Agglutination Test

6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Molecular Diagnostics

6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Others

6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

7. Global Infectious Disease Point of Care Diagnostics Market, Disease Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1. HIV

7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Hospital Acquired Infections

7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. HBV

7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Respiratory Tract Infections

7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5. HPV

7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.6. HCV

7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.6.3. Market Opportunity Analysis

7.7. Tuberculosis

7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.7.3. Market Opportunity Analysis

7.8. COVID-19

7.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.8.3. Market Opportunity Analysis

7.9. Others

7.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.9.3. Market Opportunity Analysis

8. Global Infectious Disease Point of Care Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1. Home Care

8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Hospitals and Clinics

8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Diagnostic Laboratories

8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Academic and Research Institutes

8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Others

8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, By Technology, Disease Type, By End User, and Region, 2022-2028

10. North America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

10.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Instruments

10.1.2. Reagents and Kits

10.1.3. Software and Services

10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Lateral Flow Immunoassay

10.2.2. Agglutination Test

10.2.3. Molecular Diagnostics

10.2.4. others

10.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. HIV

10.3.2. Hospital Acquired Infections

10.3.3. HBV

10.3.4. Respiratory Tract Infections

10.3.5. HPV

10.3.6. HCV

10.3.7. Tuberculosis

10.3.8. COVID-19

10.3.9. Others

10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. Home Care

10.4.2. Hospitals and Clinics

10.4.3. Diagnostic Laboratories

10.4.4. Academic and Research Institutes

10.4.5. Others

10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. USA

10.5.2. Canada

10.6. North America Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028

10.7. North America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends

11. Europe Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

11.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Instruments

11.1.2. Reagents and Kits

11.1.3. Software and Services

11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Lateral Flow Immunoassay

11.2.2. Agglutination Test

11.2.3. Molecular Diagnostics

11.2.4. others

11.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. HIV

11.3.2. Hospital Acquired Infections

11.3.3. HBV

11.3.4. Respiratory Tract Infections

11.3.5. HPV

11.3.6. HCV

11.3.7. Tuberculosis

11.3.8. COVID-19

11.3.9. Others

11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Home Care

11.4.2. Hospitals and Clinics

11.4.3. Diagnostic Laboratories

11.4.4. Academic and Research Institutes

11.4.5. Others

11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Rest of Europe

11.6. Europe Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028

11.7. Europe Infectious Disease Point of Care Diagnostics Market Dynamics – Trends

12. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

12.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Instruments

12.1.2. Reagents and Kits

12.1.3. Software and Services

12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Lateral Flow Immunoassay

12.2.2. Agglutination Test

12.2.3. Molecular Diagnostics

12.2.4. others

12.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. HIV

12.3.2. Hospital Acquired Infections

12.3.3. HBV

12.3.4. Respiratory Tract Infections

12.3.5. HPV

12.3.6. HCV

12.3.7. Tuberculosis

12.3.8. COVID-19

12.3.9. Others

12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Home Care

12.4.2. Hospitals and Clinics

12.4.3. Diagnostic Laboratories

12.4.4. Academic and Research Institutes

12.4.5. Others

12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. China

12.5.2. India

12.5.3. Japan

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028

12.7. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Dynamics – Trends

13. Latin America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

13.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Instruments

13.1.2. Reagents and Kits

13.1.3. Software and Services

13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Lateral Flow Immunoassay

13.2.2. Agglutination Test

13.2.3. Molecular Diagnostics

13.2.4. others

13.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. HIV

13.3.2. Hospital Acquired Infections

13.3.3. HBV

13.3.4. Respiratory Tract Infections

13.3.5. HPV

13.3.6. HCV

13.3.7. Tuberculosis

13.3.8. COVID-19

13.3.9. Others

13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Home Care

13.4.2. Hospitals and Clinics

13.4.3. Diagnostic Laboratories

13.4.4. Academic and Research Institutes

13.4.5. Others

13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028

13.7. Latin America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends

14. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

14.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Instruments

14.1.2. Reagents and Kits

14.1.3. Software and Services

14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. Lateral Flow Immunoassay

14.2.2. Agglutination Test

14.2.3. Molecular Diagnostics

14.2.4. others

14.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. HIV

14.3.2. Hospital Acquired Infections

14.3.3. HBV

14.3.4. Respiratory Tract Infections

14.3.5. HPV

14.3.6. HCV

14.3.7. Tuberculosis

14.3.8. COVID-19

14.3.9. Others

14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Home Care

14.4.2. Hospitals and Clinics

14.4.3. Diagnostic Laboratories

14.4.4. Academic and Research Institutes

14.4.5. Others

14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. South Africa

14.5.3. Rest of MEA

14.6. MEA Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028

14.7. MEA Infectious Disease Point of Care Diagnostics Market Dynamics – Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Cepheid Inc. (Danaher Corporation) (U.S.)

15.2.2. Abbott Laboratories, Inc. (U.S.)

15.2.3. Hoffmann La Roche Limited (Switzerland)

15.2.4. Beckman Coulter, Inc. (U.S.)

15.2.5. Siemens AG (Germany)

15.2.6. Johnson & Johnson Services, Inc. (U.S.)

15.2.7. Instrumentation Laboratory (U.S.)

15.2.8. Becton, Dickinson and Company (U.S.)

15.2.9. Alere Inc. (U.S.)

15.2.10. Nova Biomedical (U.S.)

15.2.11. Thermo Fisher Scientific Inc. (U.S.)

15.2.12. Quidel Corporation (U.S.)

16. Research Methodology

17. Key Assumptions and Acronyms

Description
Reviews (0)

Description

Key Development:

In April 2021 Chembio Diagnostics, Inc. launched the rapid point-of-care COVID-19/flu A&B test. The test provides results in 15 min.

Reviews

There are no reviews yet.

Be the first to review “Infectious diseases Point-of-Care (POC) Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

search

Infectious diseases Point-of-Care (POC) Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Description

Key Development:

Infectious Diseases Point-of-Care (POC) Diagnostic

Drivers

Infectious diseases Point-of-Care (POC) Diagnostic Market

By Component Type

By Technology

By Disease type

By End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Key Development:

Reviews

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE